Day 8 monocyte and lymphocyte counts as a novel and early predictor for discontinuation in gynecologic cancer patients receiving paclitaxel and carboplatin therapy: a retrospective observational study
Abstract Background Maintaining optimal treatment intensity is essential for therapeutic efficacy in gynecological malignancies undergoing paclitaxel plus carboplatin (TC) chemotherapy; however, myelosuppression frequently results in treatment delay or interruption, which can compromise long-term ou...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2026-02-01
|
| Serie: | Journal of Pharmaceutical Health Care and Sciences |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s40780-026-00547-5 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|